Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Oramed Pharmaceuticals Inc. (ORMP)

4.1100 -0.1200 (-2.84%)
At close: October 30 at 4:00:00 PM EDT
4.1300 +0.0200 (+0.49%)
After hours: October 30 at 4:00:11 PM EDT
Trade ORMP on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
2,000
0
1,340
2,703
Cost of Revenue
0
1,987
0
--
--
Gross Profit
0
13
0
--
--
Operating Expense
14,524
15,101
12,781
17,109
43,301
Operating Income
-14,524
-15,088
-12,781
-15,769
-40,598
Net Non Operating Interest Income Expense
137,551
1,767
4,103
4,589
3,564
Other Income Expense
97,248
88,645
-7,242
16,268
-630
Pretax Income
220,275
75,324
-15,920
5,088
-37,664
Tax Provision
45,411
11,308
3,183
0
100
Net Income Common Stockholders
174,870
64,050
-19,060
5,525
-36,561
Diluted NI Available to Com Stockholders
174,870
64,050
-19,060
5,525
-36,561
Basic EPS
4.24
1.53
-0.48
0.14
-0.94
Diluted EPS
4.13
1.50
-0.48
0.14
-0.94
Basic Average Shares
41,112.4540
41,402.9970
40,850.4460
40,315.0680
38,997.6490
Diluted Average Shares
42,094.8700
42,418.6440
40,850.4460
40,566.9010
38,997.6490
Total Operating Income as Reported
-14,524
-15,088
-12,781
-15,769
-40,598
Total Expenses
14,524
17,088
12,781
17,109
43,301
Net Income from Continuing & Discontinued Operation
174,870
64,050
-19,060
5,525
-36,561
Normalized Income
105,260.1960
-10,473.0072
-13,674.1246
-10,743
-36,093.6030
Interest Income
138,157
2,373
4,983
8,169
3,573
Interest Expense
--
0
853
2,037
0
Net Interest Income
137,551
1,767
4,103
4,589
3,564
EBIT
75,888
75,324
-15,067
7,125
-37,664
EBITDA
76,010
75,445
-14,874
7,321
-37,606
Reconciled Cost of Revenue
0
1,987
0
--
--
Reconciled Depreciation
122
121
193
196
58
Net Income from Continuing Operation Net Minority Interest
174,870
64,050
-19,060
5,525
-36,561
Total Unusual Items Excluding Goodwill
87,687
87,687
-7,242
16,268
-630
Total Unusual Items
87,687
87,687
-7,242
16,268
-630
Normalized EBITDA
-11,677
-12,242
-7,632
-8,947
-36,976
Tax Rate for Calcs
0.0002
0.0002
0.0003
0
0.0003
Tax Effect of Unusual Items
18,077.1960
13,163.9928
-1,856.1246
0
-162.6030
12/31/2022 - 5/1/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: